2020 International Experience Exchange with Patient Organisations
The 12th IEEPO (IEEPO 2020) explored how healthcare can move From Chance to Choice, inviting attendees to create the future of healthcare together. Co-creation, collaboration and exchange with representatives from a range of disease areas has played a big part in this year’s IEEPO, with leaders in global patient advocacy involved from the start in shaping the agenda and content. Key themes included the power of data, the digitalisation of healthcare, and exploring real life stories of personalised healthcare across the entire healthcare system.
See highlights from the full virtual IEEPO 2020 programme below...
This eBook reflects the collective effort of representatives from more than 40 patient organisations worldwide who initially prepared these project posters for a best practice exhibition for Berlin during IEEPO 2020.
During the months that followed many of you asked us to find another way of sharing these best practices despite our inability to meet in person. This eBook is the result. We hope it will inspire discussion and debate as well as acting as a valuable resource for you and your team.
Hear opinions from global leaders in patient advocacy on how healthcare is transforming to a more personalised future, the opportunities and challenges for our healthcare systems, and practical guidance on how you can initiate local change to improve the experiences of people living with diseases. These can be found on the resources page.
If you wish to use the webisodes or have any questions regarding their content, please contact us.
Virtual World Cafe: Experience Exchange
This was a patient-advocate-led discussion with break-out groups exchanging their views on key questions identified by the patient community.
Transformation of healthcare:
How can we advocate for a healthcare ecosystem catering for equal access to personalised healthcare and related solutions?
Partnership for impact on policy making:
What can patient organisations do to strengthen partnerships with national governments and other ecosystem stakeholders in order to impact policy decisions?
Responding to the COVID-19 pandemic:
What can patient organisations do to support the continuation of treatment and care during these challenging times?